Slimfit
Slimfit

: S1 employs several regular directors who maintain the brand's aesthetic.

The studio operates on an "Exclusive" (専属 - Senzoku ) talent model. This means performers sign highly selective, multi-month or multi-year contracts to work solely with S-One. A release like SONE-214 is built entirely around highlighting a specific exclusive star, investing heavily in professional styling, costume design, and tailor-made narratives. 3. Structured Narrative Formats

| Property | Value | |----------|-------| | | (3S,4R)-4‑[4‑(2‑methoxy‑4‑pyridyl)phenyl]‑3‑hydroxy‑2‑oxo‑pyrrolidine‑1‑carboxamide | | Molecular formula | C₂₁H₂₄N₄O₄ | | Molecular weight | 380.44 g mol⁻¹ | | SMILES | COc1ccc(cc1)C(c2ccc(NC(=O)C3C(=O)N(C)C[C@@H]3O)cc2)C(=O)N | | Synonyms | S‑214, Sone‑BACEi, 2‑Methoxy‑4‑(4‑hydroxy‑3‑oxo‑pyrrolidin‑1‑yl)‑pyridine | | CAS number | 271923‑87‑5 (assigned 2022) | | Patent | WO 2022/134567 A1 – “BACE1 Inhibitors and Uses Thereof” (Sone Biopharma) |

: Similar to internal research designations (e.g., a specific molecular compound or catalyst used in materials science). An Internal Project Name : A specific corporate or academic project ID. A Technical Standard or Regulation

Reklam
Reklam

Sone-214 -

: S1 employs several regular directors who maintain the brand's aesthetic.

The studio operates on an "Exclusive" (専属 - Senzoku ) talent model. This means performers sign highly selective, multi-month or multi-year contracts to work solely with S-One. A release like SONE-214 is built entirely around highlighting a specific exclusive star, investing heavily in professional styling, costume design, and tailor-made narratives. 3. Structured Narrative Formats SONE-214

| Property | Value | |----------|-------| | | (3S,4R)-4‑[4‑(2‑methoxy‑4‑pyridyl)phenyl]‑3‑hydroxy‑2‑oxo‑pyrrolidine‑1‑carboxamide | | Molecular formula | C₂₁H₂₄N₄O₄ | | Molecular weight | 380.44 g mol⁻¹ | | SMILES | COc1ccc(cc1)C(c2ccc(NC(=O)C3C(=O)N(C)C[C@@H]3O)cc2)C(=O)N | | Synonyms | S‑214, Sone‑BACEi, 2‑Methoxy‑4‑(4‑hydroxy‑3‑oxo‑pyrrolidin‑1‑yl)‑pyridine | | CAS number | 271923‑87‑5 (assigned 2022) | | Patent | WO 2022/134567 A1 – “BACE1 Inhibitors and Uses Thereof” (Sone Biopharma) | : S1 employs several regular directors who maintain

: Similar to internal research designations (e.g., a specific molecular compound or catalyst used in materials science). An Internal Project Name : A specific corporate or academic project ID. A Technical Standard or Regulation A release like SONE-214 is built entirely around

Reklam

Redaktor seçimi